2020年

日本神経学会による災害対策:神経難病リエゾン活動の推進
中根俊成、溝口功一、阿部康二、熱田直樹、井口保之、池田佳生、梶龍兒、亀井聡、北川一夫、木村和美、鈴木正彦、髙嶋博、寺山靖夫、西山和利、古谷博和、松原悦朗、村松慎一、山村修、武田篤、伊東秀文. 日本神経学会災害対策委員会 臨床神経学 総説 2020
Myositis with sarcoplasmic inclusions in Nakajo-Nishimura syndrome: a genetic inflammatory myopathy.
Ayaki T, Murata K, Kanazawa N, Uruha A, Ohmura K, Sugie K, Kasagi S, Li F, Mori M, Nakajima R, Sasai T, Nishino I, Ueno S, Urushitani M, Furukawa F, Ito H, Takahashi R. Neuropathol Appl Neurobiol. 2020 Oct;46(6):579-587. doi: 10.1111/nan.12614
Real-world safety and effectiveness of rotigotine in patients with Parkinson’s disease: analysis of a post-marketing surveillance study in Japan.
Ito H, Takayama T, Kondo H, Fukuta Y Int J Neurosci. 2020 Aug 26:1-11. doi: 10.1080/00207454.2020.1807976.
Association between oxidative stress and microRNA expression pattern of ALS patients in the high-incidence area of the Kii Peninsula
Arakawa Y, Itoh S, Fukazawa Y, Ishiguchi H, Kohmoto J, Hironishi M, Ito H, Kihira T. Brain Res. 2020 Nov 1;1746:147035. doi: 10.1016/j.brainres.2020.147035.
Increased large-scale inter-network connectivity in relation to impulsivity in Parkinson's disease.
Koh J, Kaneoke Y, Donishi T, Ishida T, Sakata M, Hiwatani Y, Nakayama Y, Yasui M, Ishiguchi H, Hironishi M, Murata KY, Terada M, Ito H. Sci Rep. 2020 Jul 10;10(1):11418. doi: 10.1038/s41598-020-68266-x
Accumulation of HAX-1 and PARL in brainstem- and cortical-type Lewy bodies in Parkinson's disease and dementia with Lewy bodies
Kawamoto Y, Ayaki T, Urushitani M, Ito H, Takahashi R. J Neurol Sci. 2020 Aug 15;415:116928. doi: 10.1016/j.jns.2020.116928.
Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan.
Li Y, Ikeda A, Yoshino H, Oyama G, Kitani M, Daida K, Hayashida A, Ogaki K, Yoshida K, Kimura T, Nakayama Y, Ito H, Sugeno N, Aoki M, Miyajima H, Kimura K, Ueda N, Watanabe M, Urabe T, Takanashi M, Funayama M, Nishioka K, Hattori N. J Hum Genet. 2020 Sep;65(9):771-781. doi: 10.1038/s10038-020-0772-4.
EF hand-like motif mutations of Nav1.4 C-terminus cause myotonic syndrome by impairing fast inactivation.
Horie R, Kubota T, Koh J, Tanaka R, Nakamura Y, Sasaki R, Ito H, Takahashi MP. Muscle Nerve. 2020 Jun;61(6):808-814. doi: 10.1002/mus.26849.
Linear Ubiquitin Code: Its Writer, Erasers, Decoders, Inhibitors, and Implications in Disorders
Oikawa D, Sato Y, Ito H, Tokunaga F. Int J Mol Sci. 2020 May 11;21(9):E3381. doi: 10.3390/ijms21093381.
Autoimmune polyglandular syndrome type 2 and autoimmune hepatitis with thymoma-associated myasthenia gravis: case report.
Inaba H, Ariyasu H, Iwakura H, Kurimoto C, Ueda Y, Uraki S, Takeshima K, Furukawa Y, Morita S, Nakayama Y, Ohashi T, Ito H, Nishimura Y, Akamizu T. BMC Endocr Disord. 2020 Apr 7;20(1):47. doi: 10.1186/s12902-020-0498-5.
Linear Polyubiquitin Chain Modification of TDP-43-Positive Neuronal Cytoplasmic Inclusions in Amyotrophic Lateral Sclerosis.
Nakayama Y, Tsuji K, Ayaki T, Mori M, Tokunaga F, Ito H. J Neuropathol Exp Neurol. 2020 Mar 1;79(3):256-265. doi: 10.1093/jnen/nlz135.
The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1.
Hayashida A, Li Y, Yoshino H, Daida K, Ikeda A, Ogaki K, Fuse A, Mori A, Takanashi M, Nakahara T, Yoritaka A, Tomizawa Y, Furukawa Y, Kanai K, Nakayama Y, Ito H, Ogino M, Hattori Y, Hattori T, Ichinose Y, Takiyama Y, Saito T, Kimura T, Aizawa H, Shoji H, Mizuno Y, Matsushita T, Sato M, Sekijima Y, Morita M, Iwasaki A, Kusaka H, Tada M, Tanaka F, Sakiyama Y, Fujimoto T, Nagara Y, Kashihara K, Todo H, Nakao K, Tsuruta K, Yoshikawa M, Hara H, Yokote H, Murase N, Nakamagoe K, Tamaoka A, Takamiya M, Morimoto N, Nokura K, Kako T, Funayama M, Nishioka K, Hattori N. Neurobiol Aging. 2021 Jan;97:146.e1-146.e13. doi: 10.1016/j.neurobiolaging.2020年06月01日7. Epub 2020 Jul 2.

PAGE TOP

AltStyle によって変換されたページ (->オリジナル) /